Five Alarm Bio writes...we are delighted to announce the close of our seed investment to further advance our pioneering antiaging research.
The funding will enable our team to test new compounds for their ability to extend the healthy lifespan of cells and improve their function in disease-relevant models. By targeting an unexplored mechanism of aging, these compounds have the potential to delay or prevent the onset of a broad range of age-related diseases, such as arthritis, sarcopenia and Alzheimers Disease.
A huge thank you to Cambridge Angels, KPMGAcceleris, Meltwind, o2h Ventures, and SyndicateRoom for supporting us in this round.
To learn more, please visit www.fivealarmbio.com
